---
title: MMS Holdings vs ProPharma Group
slug_a: mmsholdings
slug_b: propharmagroup
site: cro
review_signal_gate: closed
canonical_path: /compare/mmsholdings/propharmagroup
---

# MMS Holdings vs ProPharma Group

Side-by-side profile data from each company listing on this directory.

## MMS Holdings

- Profile: [/companies/mmsholdings](/companies/mmsholdings)

MMS Holdings — Data-focused CRO providing full-spectrum biometrics, regulatory submissions, safety & risk management, and therapeutic expertise across oncology, CNS, rare diseases, and psychedelics. Named Best Specialist CRO at the Scrip Awards with zero refusals to file on 50+ marketing applications in five years.

Services: 14. Modalities: 5. Indications: 5. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (14).

### Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Regulatory Affairs
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- Japan PMDA Regulatory Strategy
- China NMPA Regulatory Strategy

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Vaccine
- Radiopharmaceutical

### Indications

- Oncology
- Neurology
- Psychiatry
- Infectious Disease
- Rare Disease

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV
- Real-World Evidence (RWE) / Registries

### Sourcing models

- Full-Service Outsourcing (FSO)
- Functional Service Provider (FSP)

## ProPharma Group

- Profile: [/companies/propharmagroup](/companies/propharmagroup)

ProPharma Group — ProPharma Group provides pharmacovigilance, regulatory sciences, medical information, medical writing, and biostatistics services to life sciences companies. Its regulatory offering covers FDA and European work, including an AI-assisted capability for ANDA submission development.

Services: 7. Modalities: 0. Indications: 0. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (7).

### Services

- Clinical Operations
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Regulatory Affairs
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy

### Modalities

- Data not yet provided.

### Indications

- Data not yet provided.

### Phases

- Data not yet provided.

### Sourcing models

- Data not yet provided.